A New Protocol for Continuous Vancomycin Infusion Dosing. (CVIP)

Karolinska University Hospital

Status: Completed

Conditions: Vancomycin Treatment; Sepsis

Treatments: Other: Plasma vancoymcin measurements

Study type: Observational

Funder types: Other

Identifiers

NCT05143645

K 2019-9605

Details and patient eligibility

About

This observational study prospectively collect data on chosen dosing, renal function, measured plasma concentrations and adherence to the recommended clinical protocl for ICU patients treated with continuous vancomycin infusion.

Enrollment: 101 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Start of continuous vancomycin infusion during the course of intensive care and at least one measurement of plasma concentration.

Exclusion criteria

• Vancomycin treatment within 96 h before admission to the unit.
• Vancomycin treatment started with intermittent bolus infusions.